Loading…
Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis : hepatitis B virus : inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines?
Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis - hepatitis B virus - inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines? The immunogenic responses and local reactions to four...
Saved in:
Published in: | European journal of pediatrics 1999-05, Vol.158 (5), p.398-402 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c345t-cf9d9ac8e56f5199066a7aa913cb4c167e6616bbc07d7eb87b82bfdbc50b6d413 |
---|---|
cites | |
container_end_page | 402 |
container_issue | 5 |
container_start_page | 398 |
container_title | European journal of pediatrics |
container_volume | 158 |
creator | USONIS, V BAKASENAS, V |
description | Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis - hepatitis B virus - inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines? The immunogenic responses and local reactions to four Haemophilus influenzae type b (Hib) conjugate vaccines licensed for primary immunisation (Hiberix, ActHib, Pedvax, HibTITER) when administered concomitantly but in the opposite thigh with a candidate diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus vaccine were studied in 549 healthy infants at 3, 4.5 and 6 months of age. Local reactions were mild, but different between the four groups, a tetanus conjugate Hib vaccine showing the fewest reactions. All local reactions resolved without sequelae. There was no apparent general reaction. The immunogenic response was similar with all four vaccines, geometric mean concentrations ranging from 4.95 to 7.2 microg/ml. All but one subject had antipolyribosylribitol phosphate polysaccharide antibody titres > or =0.15 microg/ml, and 88.0% to 96% achieved high titres (>1.0 microg/ml) generally associated with long-term protection against Hib disease.
There does not appear to be any interference with the immune response when current commercial Haemophilus influenzae type b conjugate vaccines are concomitantly administered with a candidate diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus vaccine as separate injections. |
doi_str_mv | 10.1007/s004310051100 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69767436</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69767436</sourcerecordid><originalsourceid>FETCH-LOGICAL-c345t-cf9d9ac8e56f5199066a7aa913cb4c167e6616bbc07d7eb87b82bfdbc50b6d413</originalsourceid><addsrcrecordid>eNpdkk2P0zAQhiMEYsvCkSuyEOIWsOPUbrggWD4WaSUucI7GzmTrKrGDPyqV_82dqVq0wMUezTx63_F4quqp4K8E5_p14ryVFK0FHfeqlWhlUwuu1f1qxWXLayW67qJ6lNKOE9-JzcPqQnAppWjkqvr1IWBiNngbZpfBZ-b8Dm12wbMwMqDSbJzHgQ1u2eYtRgd1RiJLqsHiNJUJIlsw5pKSS-wN2-IC2WWK37O9i-WYcx5Icw-ZhJYwuXCu7MFaUqf6OBX0FhlZsIhEh1v0zrp8YOAH5ua5-LsUtUaNzRitg4ldA85h2bqJFM9KP4GkDgsyc3zcrtyS9R-39PZx9WCEKeGT831Zff_08dvVdX3z9fOXq3c3tZXtOtd27IYO7AbXalzTGLlSoAE6Ia1prVAalRLKGMv1oNFstNk0ZhyMXXOjhlbIy-rlSXeJ4UfBlPvZpePQwGMoqVedVrqVisDn_4G7UKKn3vqmEZtO008SVJ8gG0NKEcd-iW6GeOgF74_L0P-zDMQ_O4sWM-PwF336fQJenAFIFqYxgrcu3XFaNWQrfwP9K8OF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221897340</pqid></control><display><type>article</type><title>Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis : hepatitis B virus : inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines?</title><source>Springer Link</source><creator>USONIS, V ; BAKASENAS, V</creator><creatorcontrib>USONIS, V ; BAKASENAS, V</creatorcontrib><description>Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis - hepatitis B virus - inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines? The immunogenic responses and local reactions to four Haemophilus influenzae type b (Hib) conjugate vaccines licensed for primary immunisation (Hiberix, ActHib, Pedvax, HibTITER) when administered concomitantly but in the opposite thigh with a candidate diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus vaccine were studied in 549 healthy infants at 3, 4.5 and 6 months of age. Local reactions were mild, but different between the four groups, a tetanus conjugate Hib vaccine showing the fewest reactions. All local reactions resolved without sequelae. There was no apparent general reaction. The immunogenic response was similar with all four vaccines, geometric mean concentrations ranging from 4.95 to 7.2 microg/ml. All but one subject had antipolyribosylribitol phosphate polysaccharide antibody titres > or =0.15 microg/ml, and 88.0% to 96% achieved high titres (>1.0 microg/ml) generally associated with long-term protection against Hib disease.
There does not appear to be any interference with the immune response when current commercial Haemophilus influenzae type b conjugate vaccines are concomitantly administered with a candidate diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus vaccine as separate injections.</description><identifier>ISSN: 0340-6199</identifier><identifier>EISSN: 1432-1076</identifier><identifier>DOI: 10.1007/s004310051100</identifier><identifier>PMID: 10333123</identifier><identifier>CODEN: EJPEDT</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject><![CDATA[Antibodies, Bacterial - biosynthesis ; Antibodies, Viral - biosynthesis ; Bacterial Capsules ; Bacterial Proteins - administration & dosage ; Bacterial Proteins - immunology ; Biological and medical sciences ; Diphtheria-Tetanus-acellular Pertussis Vaccines ; Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage ; Diphtheria-Tetanus-Pertussis Vaccine - immunology ; Epidemiology. Vaccinations ; General aspects ; Haemophilus Vaccines - administration & dosage ; Haemophilus Vaccines - immunology ; Hepatitis B Vaccines - administration & dosage ; Hepatitis B Vaccines - immunology ; Humans ; Infant ; Infectious diseases ; Medical sciences ; Poliovirus Vaccine, Inactivated - administration & dosage ; Poliovirus Vaccine, Inactivated - immunology ; Polysaccharides, Bacterial - administration & dosage ; Polysaccharides, Bacterial - immunology ; Tetanus Toxoid - administration & dosage ; Tetanus Toxoid - immunology ; Vaccination - adverse effects ; Vaccines, Combined - administration & dosage ; Vaccines, Combined - immunology ; Vaccines, Conjugate - administration & dosage ; Vaccines, Conjugate - immunology]]></subject><ispartof>European journal of pediatrics, 1999-05, Vol.158 (5), p.398-402</ispartof><rights>1999 INIST-CNRS</rights><rights>Springer-Verlag Berlin Heidelberg 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c345t-cf9d9ac8e56f5199066a7aa913cb4c167e6616bbc07d7eb87b82bfdbc50b6d413</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1762403$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10333123$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>USONIS, V</creatorcontrib><creatorcontrib>BAKASENAS, V</creatorcontrib><title>Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis : hepatitis B virus : inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines?</title><title>European journal of pediatrics</title><addtitle>Eur J Pediatr</addtitle><description>Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis - hepatitis B virus - inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines? The immunogenic responses and local reactions to four Haemophilus influenzae type b (Hib) conjugate vaccines licensed for primary immunisation (Hiberix, ActHib, Pedvax, HibTITER) when administered concomitantly but in the opposite thigh with a candidate diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus vaccine were studied in 549 healthy infants at 3, 4.5 and 6 months of age. Local reactions were mild, but different between the four groups, a tetanus conjugate Hib vaccine showing the fewest reactions. All local reactions resolved without sequelae. There was no apparent general reaction. The immunogenic response was similar with all four vaccines, geometric mean concentrations ranging from 4.95 to 7.2 microg/ml. All but one subject had antipolyribosylribitol phosphate polysaccharide antibody titres > or =0.15 microg/ml, and 88.0% to 96% achieved high titres (>1.0 microg/ml) generally associated with long-term protection against Hib disease.
There does not appear to be any interference with the immune response when current commercial Haemophilus influenzae type b conjugate vaccines are concomitantly administered with a candidate diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus vaccine as separate injections.</description><subject>Antibodies, Bacterial - biosynthesis</subject><subject>Antibodies, Viral - biosynthesis</subject><subject>Bacterial Capsules</subject><subject>Bacterial Proteins - administration & dosage</subject><subject>Bacterial Proteins - immunology</subject><subject>Biological and medical sciences</subject><subject>Diphtheria-Tetanus-acellular Pertussis Vaccines</subject><subject>Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage</subject><subject>Diphtheria-Tetanus-Pertussis Vaccine - immunology</subject><subject>Epidemiology. Vaccinations</subject><subject>General aspects</subject><subject>Haemophilus Vaccines - administration & dosage</subject><subject>Haemophilus Vaccines - immunology</subject><subject>Hepatitis B Vaccines - administration & dosage</subject><subject>Hepatitis B Vaccines - immunology</subject><subject>Humans</subject><subject>Infant</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Poliovirus Vaccine, Inactivated - administration & dosage</subject><subject>Poliovirus Vaccine, Inactivated - immunology</subject><subject>Polysaccharides, Bacterial - administration & dosage</subject><subject>Polysaccharides, Bacterial - immunology</subject><subject>Tetanus Toxoid - administration & dosage</subject><subject>Tetanus Toxoid - immunology</subject><subject>Vaccination - adverse effects</subject><subject>Vaccines, Combined - administration & dosage</subject><subject>Vaccines, Combined - immunology</subject><subject>Vaccines, Conjugate - administration & dosage</subject><subject>Vaccines, Conjugate - immunology</subject><issn>0340-6199</issn><issn>1432-1076</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNpdkk2P0zAQhiMEYsvCkSuyEOIWsOPUbrggWD4WaSUucI7GzmTrKrGDPyqV_82dqVq0wMUezTx63_F4quqp4K8E5_p14ryVFK0FHfeqlWhlUwuu1f1qxWXLayW67qJ6lNKOE9-JzcPqQnAppWjkqvr1IWBiNngbZpfBZ-b8Dm12wbMwMqDSbJzHgQ1u2eYtRgd1RiJLqsHiNJUJIlsw5pKSS-wN2-IC2WWK37O9i-WYcx5Icw-ZhJYwuXCu7MFaUqf6OBX0FhlZsIhEh1v0zrp8YOAH5ua5-LsUtUaNzRitg4ldA85h2bqJFM9KP4GkDgsyc3zcrtyS9R-39PZx9WCEKeGT831Zff_08dvVdX3z9fOXq3c3tZXtOtd27IYO7AbXalzTGLlSoAE6Ia1prVAalRLKGMv1oNFstNk0ZhyMXXOjhlbIy-rlSXeJ4UfBlPvZpePQwGMoqVedVrqVisDn_4G7UKKn3vqmEZtO008SVJ8gG0NKEcd-iW6GeOgF74_L0P-zDMQ_O4sWM-PwF336fQJenAFIFqYxgrcu3XFaNWQrfwP9K8OF</recordid><startdate>19990501</startdate><enddate>19990501</enddate><creator>USONIS, V</creator><creator>BAKASENAS, V</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>19990501</creationdate><title>Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis : hepatitis B virus : inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines?</title><author>USONIS, V ; BAKASENAS, V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c345t-cf9d9ac8e56f5199066a7aa913cb4c167e6616bbc07d7eb87b82bfdbc50b6d413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Antibodies, Bacterial - biosynthesis</topic><topic>Antibodies, Viral - biosynthesis</topic><topic>Bacterial Capsules</topic><topic>Bacterial Proteins - administration & dosage</topic><topic>Bacterial Proteins - immunology</topic><topic>Biological and medical sciences</topic><topic>Diphtheria-Tetanus-acellular Pertussis Vaccines</topic><topic>Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage</topic><topic>Diphtheria-Tetanus-Pertussis Vaccine - immunology</topic><topic>Epidemiology. Vaccinations</topic><topic>General aspects</topic><topic>Haemophilus Vaccines - administration & dosage</topic><topic>Haemophilus Vaccines - immunology</topic><topic>Hepatitis B Vaccines - administration & dosage</topic><topic>Hepatitis B Vaccines - immunology</topic><topic>Humans</topic><topic>Infant</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Poliovirus Vaccine, Inactivated - administration & dosage</topic><topic>Poliovirus Vaccine, Inactivated - immunology</topic><topic>Polysaccharides, Bacterial - administration & dosage</topic><topic>Polysaccharides, Bacterial - immunology</topic><topic>Tetanus Toxoid - administration & dosage</topic><topic>Tetanus Toxoid - immunology</topic><topic>Vaccination - adverse effects</topic><topic>Vaccines, Combined - administration & dosage</topic><topic>Vaccines, Combined - immunology</topic><topic>Vaccines, Conjugate - administration & dosage</topic><topic>Vaccines, Conjugate - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>USONIS, V</creatorcontrib><creatorcontrib>BAKASENAS, V</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>USONIS, V</au><au>BAKASENAS, V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis : hepatitis B virus : inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines?</atitle><jtitle>European journal of pediatrics</jtitle><addtitle>Eur J Pediatr</addtitle><date>1999-05-01</date><risdate>1999</risdate><volume>158</volume><issue>5</issue><spage>398</spage><epage>402</epage><pages>398-402</pages><issn>0340-6199</issn><eissn>1432-1076</eissn><coden>EJPEDT</coden><abstract>Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis - hepatitis B virus - inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines? The immunogenic responses and local reactions to four Haemophilus influenzae type b (Hib) conjugate vaccines licensed for primary immunisation (Hiberix, ActHib, Pedvax, HibTITER) when administered concomitantly but in the opposite thigh with a candidate diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus vaccine were studied in 549 healthy infants at 3, 4.5 and 6 months of age. Local reactions were mild, but different between the four groups, a tetanus conjugate Hib vaccine showing the fewest reactions. All local reactions resolved without sequelae. There was no apparent general reaction. The immunogenic response was similar with all four vaccines, geometric mean concentrations ranging from 4.95 to 7.2 microg/ml. All but one subject had antipolyribosylribitol phosphate polysaccharide antibody titres > or =0.15 microg/ml, and 88.0% to 96% achieved high titres (>1.0 microg/ml) generally associated with long-term protection against Hib disease.
There does not appear to be any interference with the immune response when current commercial Haemophilus influenzae type b conjugate vaccines are concomitantly administered with a candidate diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus vaccine as separate injections.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>10333123</pmid><doi>10.1007/s004310051100</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0340-6199 |
ispartof | European journal of pediatrics, 1999-05, Vol.158 (5), p.398-402 |
issn | 0340-6199 1432-1076 |
language | eng |
recordid | cdi_proquest_miscellaneous_69767436 |
source | Springer Link |
subjects | Antibodies, Bacterial - biosynthesis Antibodies, Viral - biosynthesis Bacterial Capsules Bacterial Proteins - administration & dosage Bacterial Proteins - immunology Biological and medical sciences Diphtheria-Tetanus-acellular Pertussis Vaccines Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage Diphtheria-Tetanus-Pertussis Vaccine - immunology Epidemiology. Vaccinations General aspects Haemophilus Vaccines - administration & dosage Haemophilus Vaccines - immunology Hepatitis B Vaccines - administration & dosage Hepatitis B Vaccines - immunology Humans Infant Infectious diseases Medical sciences Poliovirus Vaccine, Inactivated - administration & dosage Poliovirus Vaccine, Inactivated - immunology Polysaccharides, Bacterial - administration & dosage Polysaccharides, Bacterial - immunology Tetanus Toxoid - administration & dosage Tetanus Toxoid - immunology Vaccination - adverse effects Vaccines, Combined - administration & dosage Vaccines, Combined - immunology Vaccines, Conjugate - administration & dosage Vaccines, Conjugate - immunology |
title | Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis : hepatitis B virus : inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines? |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T18%3A06%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Does%20concomitant%20injection%20of%20a%20combined%20diphtheria-tetanus-acellular%20pertussis%20:%20hepatitis%20B%20virus%20:%20inactivated%20polio%20virus%20vaccine%20influence%20the%20reactogenicity%20and%20immunogenicity%20of%20commercial%20Haemophilus%20influenzae%20type%20b%20conjugate%20vaccines?&rft.jtitle=European%20journal%20of%20pediatrics&rft.au=USONIS,%20V&rft.date=1999-05-01&rft.volume=158&rft.issue=5&rft.spage=398&rft.epage=402&rft.pages=398-402&rft.issn=0340-6199&rft.eissn=1432-1076&rft.coden=EJPEDT&rft_id=info:doi/10.1007/s004310051100&rft_dat=%3Cproquest_cross%3E69767436%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c345t-cf9d9ac8e56f5199066a7aa913cb4c167e6616bbc07d7eb87b82bfdbc50b6d413%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=221897340&rft_id=info:pmid/10333123&rfr_iscdi=true |